These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30560388)

  • 1. The Influence of Cellulosic Polymer's Variables on Dissolution/Solubility of Amorphous Felodipine and Crystallization Inhibition from a Supersaturated State.
    Shi NQ; Jin Y; Zhang Y; Che XX; Xiao X; Cui GH; Chen YZ; Feng B; Li ZQ; Qi XR
    AAPS PharmSciTech; 2018 Dec; 20(1):12. PubMed ID: 30560388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.
    Konno H; Handa T; Alonzo DE; Taylor LS
    Eur J Pharm Biopharm; 2008 Oct; 70(2):493-9. PubMed ID: 18577451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.
    Chen Y; Liu C; Chen Z; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Mol Pharm; 2015 Feb; 12(2):576-89. PubMed ID: 25535667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of polymers and media type on extending the dissolution of amorphous pioglitazone and inhibiting the recrystallization from a supersaturated state.
    Shi NQ; Yao J; Wang XL
    Drug Dev Ind Pharm; 2014 Aug; 40(8):1112-22. PubMed ID: 23808528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
    Sarode AL; Malekar SA; Cote C; Worthen DR
    Carbohydr Polym; 2014 Nov; 112():512-9. PubMed ID: 25129775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the behavior of amorphous pharmaceutical systems during dissolution.
    Alonzo DE; Zhang GG; Zhou D; Gao Y; Taylor LS
    Pharm Res; 2010 Apr; 27(4):608-18. PubMed ID: 20151181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
    Xie T; Taylor LS
    Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining ibuprofen sodium with cellulosic polymers: a deep dive into mechanisms of prolonged supersaturation.
    Terebetski JL; Michniak-Kohn B
    Int J Pharm; 2014 Nov; 475(1-2):536-46. PubMed ID: 25219860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the properties of felodipine solid dispersions prepared by different technologies].
    Shi NQ; Zhang H; Zhang Y; Feng B; Li ZQ; Qi XR
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1067-1073. PubMed ID: 27987515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rules and characteristics of crystallization inhibition of cellulose polymers against drugs in supersaturated states].
    Shi NQ; Zhang Y; Zhang XR; Feng B; Li ZQ; Qi XR
    Yao Xue Xue Bao; 2016 Mar; 51(3):462-8. PubMed ID: 29859030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissolution and precipitation behavior of amorphous solid dispersions.
    Alonzo DE; Gao Y; Zhou D; Mo H; Zhang GGZ; Taylor LS
    J Pharm Sci; 2011 Aug; 100(8):3316-3331. PubMed ID: 21607951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug.
    Verma S; Rudraraju VS
    AAPS PharmSciTech; 2015 Oct; 16(5):1079-90. PubMed ID: 25672820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New Method of Constructing a Drug-Polymer Temperature-Composition Phase Diagram Using Hot-Melt Extrusion.
    Tian Y; Jones DS; Donnelly C; Brannigan T; Li S; Andrews GP
    Mol Pharm; 2018 Apr; 15(4):1379-1391. PubMed ID: 29205040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equilibrium state at supersaturated drug concentration achieved by hydroxypropyl methylcellulose acetate succinate: molecular characterization using (1)H NMR technique.
    Ueda K; Higashi K; Yamamoto K; Moribe K
    Mol Pharm; 2015 Apr; 12(4):1096-104. PubMed ID: 25723893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water-Resistant Drug-Polymer Interaction Contributes to the Formation of Nano-Species during the Dissolution of Felodipine Amorphous Solid Dispersions.
    Liu L; Chen L; Müllers W; Serno P; Qian F
    Mol Pharm; 2022 Aug; 19(8):2888-2899. PubMed ID: 35759395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Crystal Nucleation and Growth in Aqueous Drug Solutions: Impact of Different Polymers on the Supersaturation Profiles of Amorphous Drugs-The Case of Alpha-Mangostin.
    Budiman A; Citraloka ZG; Muchtaridi M; Sriwidodo S; Aulifa DL; Rusdin A
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility.
    Marsac PJ; Shamblin SL; Taylor LS
    Pharm Res; 2006 Oct; 23(10):2417-26. PubMed ID: 16933098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supersaturation, nucleation, and crystal growth during single- and biphasic dissolution of amorphous solid dispersions: polymer effects and implications for oral bioavailability enhancement of poorly water soluble drugs.
    Sarode AL; Wang P; Obara S; Worthen DR
    Eur J Pharm Biopharm; 2014 Apr; 86(3):351-60. PubMed ID: 24161655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
    Jackson MJ; Kestur US; Hussain MA; Taylor LS
    Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of polymer conformation on the crystal growth inhibition of a poorly water-soluble drug in aqueous solution.
    Schram CJ; Beaudoin SP; Taylor LS
    Langmuir; 2015; 31(1):171-9. PubMed ID: 25486041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.